A Neoantigen-Based Peptide Vaccine for Patients With Advanced Pancreatic Cancer Refractory to Standard Treatment

Overview of attention for article published in Frontiers in immunology, August 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 38 Dimensions

Readers on

mendeley: 67 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 906 followers.

New article: A Neoantigen-Based Peptide Vaccine for Patients With Advanced Pancreatic Cancer Refractory to Standard Treatment https://t.co/E7KfU8AdkC #pancreaticcancer #oncology https://t.co/HoDgpa8TaQ

Reply Repost Favourite

New article: A Neoantigen-Based Peptide Vaccine for Patients With Advanced Pancreatic Cancer Refractory to Standard Treatment https://t.co/1drsT5AYrz #prostatecancer #oncology https://t.co/Cq0AqnzFYQ

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.